Indo Us Biotech Limited — Results, 11-02-2025: Integrated Filing- Financial

Indo US Bio-Tech Limited reported standalone financial results for the quarter ending December 31, 2024, with total income reaching ₹2,358.27 cr, up from ₹2,219.07 cr in the same quarter last year. The company incurred total expenses of ₹1,856.51 cr, leading to a profit before tax of ₹501.76 cr. The net profit stood at ₹505.47 cr, reflecting solid growth given the prior profit of ₹436.95 cr.

This positive financial performance highlights strong operational efficiency and likely boosts investor confidence. The company's single product focus on seed cultivation and processing continues to streamline operations, presenting opportunities for sustained growth in the sector.